MyAverix Finance
TWO · Healthcare
Synmosa Biopharma (4114)
Drug Manufacturers - Specialty & Generic
Synmosa Biopharma (4114) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4114
Synmosa Biopharma (4114) — FAQ
What is 4114's P/E ratio?
The price-to-earnings (P/E) ratio for Synmosa Biopharma (4114) is 18.00 (data as of 2026-05-23).
Does Synmosa Biopharma pay a dividend?
Dividend yield is not available in the current snapshot for Synmosa Biopharma (4114). Check the MyAverix Finance app for the latest dividend data.
What sector is Synmosa Biopharma in?
Synmosa Biopharma (4114) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 4114 listed on?
4114 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.